{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34332578", "kind": "science-record", "revision": 7, "content_hash": "sha256:1bb44f99107bc33c70689579bd039293ff4e6b49903427de59ae1227121531b9", "created_at": "2026-11-01T15:41:46Z", "updated_at": "2026-11-01T22:04:22Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.", "doi": "10.1186/s12885-021-08550-9", "pmid": "34332578", "authors": ["Lianzi Wang", "Shubing Zhang", "Huimin Li", "Yang Xu", "Qiang Wu", "Jilong Shen", "Tao Li", "Yuanhong Xu"], "journal": "BMC cancer", "year": 2021, "abstract": "BACKGROUND: m6A is the most prevalent and abundant form of mRNA modifications and is closely related to tumor proliferation, differentiation, and tumorigenesis. In this study, we try to conduct an effective prediction model to investigated the function of m6A RNA methylation modulators in pancreatic adenocarcinoma and estimated the potential association between m6A RNA methylation modulators and tumor microenvironment infiltration for optimization of treatment.\nMETHODS: Expression of 28 m6A RNA methylation modulators and clinical data of patients with pancreatic adenocarcinoma and normal samples were obtained from TCGA and GTEx database. Differences in the expression of 28 m6A RNA methylation modulators between tumour (n = 40) and healthy (n = 167) samples were compared by Wilcoxon test. LASSO Cox regression was used to select m6A RNA methylation modulators to analyze the relationship between expression and clinical characteristics by univariate and multivariate regression. A risk score prognosis model was conducted based on the expression of select m6A RNA methylation modulators. Bioinformatics analysis was used to explore the association between the m6Ascore and the composition of infiltrating immune cells between high and low m6Ascore group by CIBERSORT algorithm. Evaluation of m6Ascore for immunotherapy was analyzed via the IPS and three immunotherapy cohort. Besides, the biological signaling pathways of the m6A RNA methylation modulators were examined by gene set enrichment analysis (GSEA).\nRESULTS: Expression of 28 m6A RNA methylation modulators were upregulated in patients with PAAD except for MTEEL3. An m6Ascore prognosis model was established, including KIAA1429, IGF2BP2, IGF2BP3, METTL3, EIF3H and LRPPRC was used to predict the prognosis of patients with PAAD, the high risk score was an independent prognostic indicator for pancreatic adenocarcinoma, and a high risk score presented a lower overall survival. In addition, m6Ascore was related with the immune cell infiltration of PAAD. Patients with a high m6Ascore had lower infiltration of Tregs and CD8+T cells but a higher resting CD4+ T infiltration. Patients with a low m6Ascore displayed a low abundance of PD-1, CTLA-4 and TIGIT, however, the IPS showed no difference between the two groups. The m6Ascore applied in three immunotherapy cohort (GSE78220, TCGA-SKCM, and IMvigor210) did not exhibit a good prediction for estimating the patients' response to immunotherapy, so it may need more researches to figure out whether the m6A modulator prognosis model would benefit the prediction of pancreatic patients' response to immunotherapy.\nCONCLUSION: Modulators involved in m6A RNA methylation were associated with the development of pancreatic cancer. An m6Ascore based on the expression of IGF2BP2, IGF2BP3, KIAA1429, METTL3, EIF3H and LRPPRC is proposed as an indicator of TME status and is instrumental in predicting the prognosis of pancreatic cancer patients.", "claims": [{"id": "claim-method", "statement": "Cox regression analysis was used to examine the prognosis of pancreatic cancer.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34332578", "locator": "sections[11] \"Statistical analysis\" paragraph 2", "quote": "Cox regression analysis was used to examine the prognosis of pancreatic cancer."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The datasets analyzed during the current study are available from TCGA database (https://cancergenome.nih.gov/), GTEx database (https://xenabrowser.net/), Immport database (https://immport.niaid.nih.gov/), TCIA database (https://www.tcia.at/home), GEO database (https://www.ncbi.nlm.nih.gov/geo/), Oncomine database (https://www.oncomine.org).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34332578", "locator": "sections[26] \"Availability of data and materials\" paragraph 2", "quote": "The datasets analyzed during the current study are available from TCGA database (https://cancergenome.nih.gov/), GTEx database (https://xenabrowser.net/), Immport database (https://immport.niaid.nih.gov/), TCIA database (https://www.tcia.at/home), GEO database (https://www.ncbi.nlm.nih.gov/geo/), Oncomine database (https://www.oncomine.org)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34332578"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34332578", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s12885-021-08550-9", "sha256": "sha256:4c2d24d41f7965c634286a41d547f1ca64c40106bd9d41c3f40645b95366563f", "bytes": 63907, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s12885-021-08550-9", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8325189", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:34332578:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:96913619bec30e260a2a8cdcfa2a180dc9f4b0a7b91fbd2e9329742ae343f4bc", "bytes": 2080, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[1]#Tab1", "version": null, "note": "the lists of the 28 m6A RNA methylation regulative factors", "structure": {"pmcid": "PMC8325189", "section_index": 4, "section_title": "Extraction of m6A RNA methylation modulator expression data", "row_count": 29, "column_count": 3}, "table": {"label": "Table 1", "caption": "the lists of the 28 m6A RNA methylation regulative factors", "rows": [["Regulators", "Full name", "Type"], ["METTL3", "Methyltransferase like 3", "“writers”"], ["METTL14", "Methyltransferase like 14", "“writers”"], ["METTL16", "Methyltransferase like 16", "“writers”"], ["WTAP", "WT1 associated protein", "“writers”"], ["RBM15", "RNA binding motif protein 15", "“writers”"], ["RBM15B", "RNA binding motif protein 15B", "“writers”"], ["ZC3H13", "Zinc finger CCCH-type containing 13", "“writers”"], ["VIRMA", "vir like m6A methyltransferase associated", "“writers”"], ["CBLL1", "Cbl proto-oncogene like 1", "“writers”"], ["ZCCHC4", "zinc finger CCHC-type containing 4", "“writers”"], ["LRPPRC", "leucine rich pentatricopeptide repeat containing", "“readers”"], ["ELAVL1", "ELAV like RNA binding protein 1", "“readers”"], ["YTHDC1", "YTH domain containing 1", "“readers”"], ["YTHDC2", "YTH domain containing 2", "“readers”"], ["YTHDF1", "YTH N6-methyladenosine RNA binding protein 1", "“readers”"], ["YTHDF2", "YTH N6-methyladenosine RNA binding protein 2", "“readers”"], ["YTHDF3", "YTH N6-methyladenosine RNA binding protein 3", "“readers”"], ["HNRNPC", "Heterogeneous nuclear ribonucleoprotein C", "“readers”"], ["HNRNPA2B1", "Heterogeneous nuclear ribonucleoprotein A2B1", "“readers”"], ["EIF3A", "Eukaryotic translation initiation factor 3 subunit A", "“readers”"], ["EIF3H", "Eukaryotic translation initiation factor 3 subunit H", "“readers”"], ["IGF2BP1", "IGF2 mRNA-binding protein 1", "“readers”"], ["IGF2BP2", "IGF2 mRNA-binding protein 2", "“readers”"], ["IGF2BP3", "IGF2 mRNA-binding protein 3", "“readers”"], ["CBLL1", "Casitas B-lineage lymphoma-transforming sequence-like protein 1", "“readers”"], ["PRRC2A", "The proline-rich coiled-coil 2A", "“readers”"], ["FTO", "Fat mass and obesity-associated protein", "“erasers”"], ["ALKBH5", "α-ketoglutarate-dependent dioxygenase AlkB homolog 5", "“erasers”"]], "row_count": 29, "column_count": 3, "numeric_cells": 27, "header_rows": 1, "locator": "section[4]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:34332578:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:24386a5394287b39a18f2a563d78ee7c152cc6f5c00209488e92b5bd05072952", "bytes": 1880, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[14]/table-wrap[1]#Tab2", "version": null, "note": "Demographic and clinicopathological parameters of PAAD patients based on TCGA datasets", "structure": {"pmcid": "PMC8325189", "section_index": 14, "section_title": "m6A RNA methylation modulators were associated with clinical characteristic of PAAD", "row_count": 49, "column_count": 5}, "table": {"label": "Table 2", "caption": "Demographic and clinicopathological parameters of PAAD patients based on TCGA datasets", "rows": [["Clinical characteristics", "All", "High m6Ascore", "low m6Ascore", "P value"], ["Age", "64.54 ± 10.81", "63.74 ± 11.68", "65.33 ± 9.88", "0.387"], ["Gender", "", "", "", "0.735"], ["Female", "66", "34", "32", ""], ["Male", "74", "36", "38", ""], ["Race", "", "", "", "0.689"], ["Asian", "8", "5", "3", ""], ["White", "123", "60", "63", ""], ["Black or African American", "5", "2", "3", ""], ["Fustat", "", "", "", "< 0.001"], ["Living", "63", "21", "42", ""], ["Deceased", "77", "49", "28", ""], ["Pathologic stage", "", "", "", "0.927"], ["I (IA + IB)", "12", "6", "6", ""], ["II (IIA + IIB)", "121", "60", "61", ""], ["III+ IV", "7", "4", "3", ""], ["T", "", "", "", "0.813"], ["T1+ T2", "21", "10", "11", ""], ["T3 + T4", "119", "60", "59", ""], ["M", "", "", "", "0.361"], ["M0", "66", "34", "32", ""], ["M1", "4", "3", "1", ""], ["N", "", "", "", "0.808"], ["N0", "37", "19", "18", ""], ["N1(N1a + N1b)", "102", "50", "52", ""], ["Histologic grade", "", "", "", "0.140"], ["G1-G2", "98", "45", "53", ""], ["G3-G4", "42", "25", "17", ""], ["Site"], ["Head of pancreas", "110", "54", "56", "0.139"], ["Body of pancreas", "11", "8", "3", ""], ["Tail of pancreas", "10", "6", "4", ""], ["others", "9", "2", "7", ""], ["Maximum tumor dimension", "3.75 ± 1.44", "4.05 ± 1.72", "3.42 ± 0.98", "0.013"], ["History of targeted molecular therapy", "", "", "", "0.185"], ["YES", "75", "37", "38", ""], ["NO", "35", "22", "13", ""], ["Alcohol drinking history", "", "", "", "0.910"], ["YES", "80", "40", "40", ""], ["NO", "49", "24", "25", ""], ["History of chronic pancreatitis", "", "", "", "0.726"], ["YES", "12", "7", "5", ""], ["NO", "100", "53", "47", ""], ["History of diabetes", "", "", "", "0.157"], ["YES", "32", "13", "19", ""], ["NO", "85", "47", "38", ""], ["Family history of cancer", "", "", "", "0.910"], ["YES", "50", "21", "29", ""], ["NO", "33", "23", "10", ""]], "row_count": 49, "column_count": 5, "numeric_cells": 118, "header_rows": 1, "locator": "section[14]/table-wrap[1]#Tab2"}}, {"id": "asset:table:pmid:34332578:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:d139a01e457ec325aa9c1c94bb504920862a3f0ddad958184df214b62f8a140c", "bytes": 2719, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[14]/table-wrap[2]#Tab3", "version": null, "note": "Association between the expression of eight m6A RNA methylation modulators and clinical characteristic in patients with PAAD based on the TCGA datasets", "structure": {"pmcid": "PMC8325189", "section_index": 14, "section_title": "m6A RNA methylation modulators were associated with clinical characteristic of PAAD", "row_count": 20, "column_count": 13}, "table": {"label": "Table 3", "caption": "Association between the expression of eight m6A RNA methylation modulators and clinical characteristic in patients with PAAD based on the TCGA datasets", "rows": [["", "EIF3H", "IGF2BP3", "IGF2BP2", "KIAA1429", "METTL3", "LRPPRC"], ["down expression", "overexpression", "down expression", "overexpression", "down expression", "overexpression", "down expression", "overexpression", "down expression", "overexpression", "down expression", "overexpression"], ["N", "70", "70", "70", "70", "70", "70", "70", "70", "70", "70", "70", "70"], ["Age", "64.54 ± 10.77", "64.53 ± 10.92", "66.57 ± 9.71", "62.50 ± 11.51", "67.46 ± 9.92", "61.61 ± 10.93", "65.51 ± 10.68", "63.56 ± 10.92", "65.77 ± 10.62", "63.30 ± 10.93", "64.66 ± 10.42", "64.41 ± 11.26"], ["P-value", "0.994", "", "0.025", "", "0.001", "", "0.286", "", "0.177", "", "0.895", ""], ["Gender"], ["female", "33 (47.14%)", "33 (47.14%)", "35 (50.00%)", "31 (44.29%)", "39 (55.71%)", "27 (38.57%)", "27 (38.57%)", "39 (55.71%)", "35 (50.00%)", "31 (44.29%)", "31 (44.29%)", "35 (50.00%)"], ["male", "37 (52.86%)", "37 (52.86%)", "35 (50.00%)", "39 (55.71%)", "31 (44.29%)", "43 (61.43%)", "43 (61.43%)", "31 (44.29%)", "35 (50.00%)", "39 (55.71%)", "39 (55.71%)", "35 (50.00%)"], ["P-value", "1.000", "", "0.498", "", "0.042", "", "0.042", "", "0.498", "", "0.498", ""], ["Maximum tumor dimension", "3.44 ± 1.03", "4.04 ± 1.70", "3.40 ± 0.96", "4.10 ± 1.74", "3.37 ± 0.95", "4.15 ± 1.74", "3.79 ± 1.57", "3.71 ± 1.30", "3.52 ± 1.14", "3.98 ± 1.68", "3.49 ± 1.07", "3.99 ± 1.69"], ["P-value", "0.016", "", "0.006", "", "0.002", "", "0.755", "", "0.069", "", "0.050", ""], ["Stage"], ["StagI (IA + IB)", "6 (8.57%)", "6 (8.57%)", "8 (11.43%)", "4 (5.71%)", "8 (11.43%)", "4 (5.71%)", "4 (5.71%)", "8 (11.43%)", "7 (10.00%)", "5 (7.14%)", "6 (8.57%)", "6 (8.57%)"], ["StagII (IIA + IIB)", "62 (88.57%)", "59 (84.29%)", "59 (84.29%)", "62 (88.57%)", "59 (84.29%)", "62 (88.57%)", "62 (88.57%)", "59 (84.29%)", "58 (82.86%)", "63 (90.00%)", "60 (85.71%)", "61 (87.14%)"], ["StagIII+IV", "2 (2.86%)", "5 (7.14%)", "3 (4.29%)", "4 (5.71%)", "3 (4.29%)", "4 (5.71%)", "4 (5.71%)", "3 (4.29%)", "5 (7.14%)", "2 (2.86%)", "4 (5.71%)", "3 (4.29%)"], ["P-value", "0.507", "", "0.461", "", "0.461", "", "0.461", "", "0.401", "", "0.927", ""], ["Grade"], ["G1 + G2", "51 (72.86%)", "47 (67.14%)", "51 (72.86%)", "47 (67.14%)", "59 (84.29%)", "39 (55.71%)", "52 (74.29%)", "46 (65.71%)", "52 (74.29%)", "46 (65.71%)", "55 (78.57%)", "43 (61.43%)"], ["G3 + G4", "19 (27.14%)", "23 (32.86%)", "19 (27.14%)", "23 (32.86%)", "11 (15.71%)", "31 (44.29%)", "18 (25.71%)", "24 (34.29%)", "18 (25.71%)", "24 (34.29%)", "15 (21.43%)", "27 (38.57%)"], ["P-value", "0.461", "", "0.461", "", "< 0.001", "", "0.268", "", "0.268", "", "0.027", ""]], "row_count": 20, "column_count": 13, "numeric_cells": 151, "header_rows": 2, "locator": "section[14]/table-wrap[2]#Tab3"}}, {"id": "asset:table:pmid:34332578:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:8c1fdbaf83302dd8d991bb7b4e90602a0bf6d4cf3cff9b0c4c9ac83ca3e33b37", "bytes": 616, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[1]#Tab4", "version": null, "note": "gene set enrichment analysis for six m6A modulators with KEGG pathway using GSEA", "structure": {"pmcid": "PMC8325189", "section_index": 16, "section_title": "The function analysis and the pathways of the genes that enriched in the group of PAAD patients with high-risk and low-risk", "row_count": 6, "column_count": 6}, "table": {"label": "Table 4", "caption": "gene set enrichment analysis for six m6A modulators with KEGG pathway using GSEA", "rows": [["Gene name", "KEGG pathway", "ES", "NES", "NOM p-val", "FDR q-val"], ["EIF3H", "KEGG_CELL_CYCLE", "0.73", "2.1", "0.000", "0.003"], ["IGF2BP2", "KEGG_BLADDER_ CANCER", "0.68", "2.07", "0.000", "0.007"], ["IGF2BP3", "KEGG_PANCREATIC_CANCER", "0.65", "1.93", "0.000", "0.006"], ["LRPPRC", "KEGG_PANCREATIC_CANCER", "0.71", "2.06", "0.000", "0.001"], ["VIRMA", "KEGG_PATHWAYS IN _CANCER", "0.64", "2.13", "0.000", "0.001"]], "row_count": 6, "column_count": 6, "numeric_cells": 20, "header_rows": 1, "locator": "section[16]/table-wrap[1]#Tab4"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Cox regression analysis was used to examine the prognosis of pancreatic cancer."}}, {"id": "method-2", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {"sample_size": "ulators between tumour (n = 40) and healthy (n = 167)"}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.7, "band": "medium", "quote": "Wilcoxon"}}, {"id": "method-3", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Kaplan-Meier"}}, {"id": "method-4", "family": "regression_modelling", "specific": "ols", "label": "Regression modelling", "dsl_operations": ["ols_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["predictors_and_outcome"], "evidence": {"score": 0.8, "band": "high", "quote": "Multiple regression"}}, {"id": "method-5", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.8, "band": "high", "quote": "pathway enrichment"}}, {"id": "method-6", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.8, "band": "high", "quote": "ROC analysis"}}, {"id": "method-7", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "Chi-square"}}], "targets": [], "gaps": ["method.reader_differs_from_extractor"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["The datasets analyzed during the current study are available from TCGA database (https://cancergenome.nih.gov/), GTEx database (https://xenabrowser.net/), Immport database (https://immport.niaid.nih.gov/), TCIA database (https://www.tcia.at/home), GEO database (https://www.ncbi.nlm.nih.gov/geo/), Oncomine database (https://www.oncomine.org)."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:34332578", "asset:table:pmid:34332578:1", "asset:table:pmid:34332578:2", "asset:table:pmid:34332578:3", "asset:table:pmid:34332578:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T19:43:42Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 51124, "completion_tokens": 3101, "cached_tokens": 776}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34332578", "type": "paper", "label": "pmid:34332578"}, {"id": "source:pmid:34332578", "type": "manuscript", "label": "PMID 34332578 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34332578", "type": "paper", "label": "pmid:34332578"}, {"id": "source:pmid:34332578", "type": "manuscript", "label": "PMID 34332578 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34332578", "type": "extraction", "used": ["source:pmid:34332578"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34332578", "parent_hash": "sha256:8454a0398576aaa1433b9b7088562d05a37b1f0dc13b9e8e4d48643cad75b3e0", "fork_of": null, "generation": 6}, "gaps": ["execution.not_run", "method.reader_differs_from_extractor", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Cox regression analysis was used to examine the prognosis of pancreatic cancer."], "order_basis": "analysis_only", "id": "assay:1"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T00:42:24+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}